Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Recombinant human pentraxin-2

EU orphan designation number: EU/3/14/1365   
Active ingredient: Recombinant human pentraxin-2
Indication: Treatment of post-polycythaemia vera myelofibrosis
Sponsor: FGK Representative Service GmbH
Heimeranstraße 35, 80339 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2014 Orphan designation EMA/OD/139/14 (2014)8859 of 19/11/2014